Heading Title
-
Summary : A new study shows why certain NK cells are activated when encountering a cell infected with SARS-CoV-2. The infected cells contain a peptide from the virus that triggers …
-
Global MarketMerger / Acquisition
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
by adminby adminSynopsis: Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and molecular diagnostics services. The acquisition, which aligns with …
-
EuropeModerna
Moderna Announces Plan to Expand Commercial Footprint in Europe Across Six Additional Countries
by adminby adminSynopsis : Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across six additional countries in Europe. Moderna plans to …
-
CompaniesEli Lilly
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
by adminby adminSynopsis : ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global, multi-year definitive licensing agreement whereby it granted Eli …
-
Global MarketPharma Science & Research
Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics
by adminby adminSummary : Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities through the acquisition of Vibalogics, a virotherapy CDMO …
-
Global MarketMerger / Acquisition
Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US
by adminby adminSynopsis : Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced the acquisition of Arranta Bio, a prominent advanced therapy CDMO. Under the stewardship of Mark Bamforth and …
-
BioNTechCompaniesGlobal MarketPharma Science & Research
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
by adminby adminSummary – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, today announced that …
-
BayerPharma Science & Research
Bayer delivers on medical innovation fueling transformation of pharma business
by adminby adminSummary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business …
-
Pharma Science & Research
Alexion and UK patient advocacy groups launch video campaign
by adminby adminSummary : Rare Disease Day has inspired a pioneering video to support patients living with rare conditions Alexion Pharma UK has launched a new video titled–‘Reforming Rare Diseases: Making the …
-
CompaniesGlobal MarketNovartis
Syncona announces sale of portfolio company to Novartis
by adminby adminSynopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale of its portfolio company, Gyroscope Therapeutics Holdings plc. …
-
Global MarketIndiaRegulatoryU.S FDA
Covaxin gets nod for human clinical trials in the US
by adminby adminSummary : After a long wait, Bharat Biotech’s Covaxin has finally got the nod from the US Food and Drug Administration (USFDA) to conduct clinical trials in humans for its …
-
Covid DrugsPharma Science & Research
Covid reinfections: Are they milder and do they strengthen immunity?
by adminby adminWe’ve known since early on in the pandemic that Covid reinfections could occur. One of the first reinfections reported was in a 33-year-old man from Hong Kong. His initial infection …
-
Synopsis: The U.S. Food and Drug Administration has approved Agios Pharmaceuticals’ candidate treatment for a rare type of hemolytic anemia. The regulator gave PYRUKYND (mitapivat) the green light for adults …
-
CompaniesGskPharma Science & Research
GSK’s Bad Week: Maternal RSV Vaccine Paused, Trade Secrets Violation Alleged
by adminby adminSynopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental maternal vaccine for respiratory syncytial virus (RSV). The studies being halted are NCT04605159, NCT04980391 and …
-
Covid DrugsPharma Science & Research
World’s First Monoclonal Antibody Prequalifies To Treat COVID
by adminby adminSynopsis: In order to increase access to treatments that are recommended to fight COVID-19, the WHO has added a monoclonal antibody treatment called Tocilizumab to its list of prequalified options …
-
Global MarketPharma Science & Research
Future of work innovation among pharma companies has dropped in the last quarter
by adminby adminSummary : Takeda Pharmaceuticals was the top Future of Work innovator in the pharmaceutical sector in the last quarter. Research and innovation in future of work in the pharmaceutical sector …
-
Agro Science & ResearchIndia
India Invites Startups and FPOs to Capitalise on Agri and Food Processing Policies at EXPO2020 Dubai
by adminby adminSummary : As part of India’s efforts to showcase the country’s investment-friendly policies and growth opportunities in agriculture and allied sectors at EXPO2020 Dubai, Dr Abhilaksh Likhi, Additional Secretary, Ministry …
-
Agro Science & ResearchIndia
AGRIM secures USD 10m from Kalaari, Axis Bank to serve USD 50bn in Agri-Inputs market
by adminby adminSummary : AGRIM has raised USD 10m in Series A funding. Kalaari Capital led the round along with Omnivore, India Quotient, and Accion Venture Lab. As part of its Bharat …
-
Agro Science & ResearchIndia
Yes Bank launches start-up enabler programme for food and agri sector
by adminby adminSummary : Private sector lender Yes Bank has launched a programme for digital financing solutions in the food and agriculture sector under its start-up enabler initiative, and it will also …
-
In 2021, EMA recommended 92 medicines for marketing authorisation. Of these, 53 had a new active substance which had never been authorised in the European Union (EU) before. This is …
-
Pharma Science & Research
New study reveals cataract surgery may reduce dementia risk in older patients
by adminby adminSummary : The overall risk for dementia was 29 per cent lower in those who had cataract surgery compared with those who did not. Surgery to remove cataracts, which cause …
-
Global MarketPharma Science & Research
HFpEF(Heart failure with preserved ejection fraction ): The deadly heart condition affecting mostly women that had no proven treatment – until now
by adminby adminSummary – Not many know about this heart condition, even though it affects 50 per cent of heart failure patients worldwide and more than 100,000 people in Singapore. Grace Tan, …
-
Global Market
Meet Sofia Jirau, Victoria’s Secret’s first model with Down Syndrome
by adminby adminSummary : It’s “a dream come true” for the Puerto Rican model, who appears in the new Love Cloud campaign, in line with the lingerie brand’s efforts to overhaul its …
-
Agro Science & Research
Growing vegetables in a mall, this Malaysian start-up wants to shake up the traditional food supply chain
by adminby adminSynopsis : Located in the Encorp Strand Mall in Petaling Jaya and occupying a 1200 square feet space next to a gymnasium is Tsubota’s urban vertical farm. When Shoma Tsubota …
-
Summary : General Motors Co and its self-driving technology unit Cruise have petitioned U.S. regulators for permission to build and deploy a self-driving vehicle without human controls like steering wheels or …
-
Synopsis : Tesla Inc changed an advertisement about the driving range for its Model 3 in South Korea after an antitrust regulator found that the automaker exaggerated the specifications of …
-
Summary : Egypt, Kenya, Nigeria, Senegal, South Africa, Tunisia selected mRNA used by Pfizer-BioNTech, Moderna for their COVID-19 shots Deal unveiled at EU-African Union summit in Brussels The World Health …
-
Summary : Certain media outlets have falsely linked Giloy/Guduchi to liver damage. The Ministry of Ayush reiterates that Giloy/Gudduchi (Tinospora cordifolia) is safe, and that according to available data, Guduchi …
-
Agro Science & ResearchIndia
Agriculture Minister Launches a Mobile Agri Knowledge Centre-‘Shashwat Bharat Krushi Rath’ in Gwalior
by adminby adminSummary – Agriculture and Farmers Welfare Minister Narendra Singh Tomar launched the ‘Shashwat Bharat Krushi Rath,’ a mobile knowledge centre, in Gwalior, Madhya Pradesh, to raise farmer awareness of globally …
-
Agro Science & Research
Israeli Man Sets a New Record by Growing World’s Heaviest Strawberry
by adminby adminSummary : According to the leading feat-tracking organization, a big strawberry cultivated in Israel that weighed 289 grammes (10.19 ounces) has been confirmed as setting a new Guinness World Record …
-
BioNTechGlobal Market
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
by adminby adminSummary : BioNTech SE (Nasdaq: BNTX, “BioNTech”) has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by …
-
Although fractures normally heal, bone will not regenerate under several circumstances. When bone does not regenerate, major clinical problems could result, including amputation. To enhance the regeneration of bone, the …
-
-
Summary : SOLOSEC® demonstrated a 92.2% clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3 clinical trial SOLOSEC® is the first and only …
-
Synopsis : Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics. Electra received $84 million in Series B financing, co-led by Westlake Village BioPartners and OrbiMed …
-
Summary : The U.S. Food and Drug Administration has accepted Mirati Therapeutics’ New Drug Application (NDA) for its candidate drug for non-small cell lung cancer (NSCLC). The NDA for adagrasib, an investigational, highly selective and …
-
Global Market
Western Potash Holdings Corp. and Vantage Chance Limited Enter Into Subscription Agreement
by adminby adminSummary : Western Resources Corp. is pleased to announce that it has signed a subscription agreement (the “Subscription Agreement”) today with Vantage Chance Limited (“Vantage”), in which Vantage has committed …
-
Pharma Science & Research
Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
by adminby adminSummary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease (MRD) in one MRD+ patient and induced epitope …
-
Global Market
VivoPower International PLC’s Kenshaw Critical Power Business Expands to New Headquarters
by adminby adminSummary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical Pty Limited (“Kenshaw”), has completed a move to …
-
CompaniesPfizer
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
by adminby adminSummary : A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to disclose the presence of cancer-causing agents in Chantix …
-
Covid DrugsGlobal Market
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
by adminby adminSummary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences in protection, suggesting an Omicron-specific booster may not …
-
Global MarketPharma Science & Research
Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs
by adminby adminSummary : Spain’s Rovi (ROVI.MC) has agreed a 10-year extension to its deal with Moderna (MRNA.O) to manufacture future drugs developed with the mRNA technology used for the U.S. company’s …
-
IndiaMankind Pharma
Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Laboratories
by adminby adminSummary : Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy’s Laboratories to acquire two brands — Combihale and Daffy. While Combihale is used for the treatment of asthma and …
-
AstraZenecaIndia
Glenmark inks pact to commercialise AstraZeneca’s asthma drug in Colombian market
by adminby adminSummary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the Colombian market. Glenmark Pharmaceuticals Colombia SAS and AstraZeneca …
-
RegulatoryU.S FDA
Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tablets
by adminby adminSummary: Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug exclusivity, Cadlia Healthcare said in a regulatory filing. …
-
India
Macleods Pharma files papers for IPO, likely to be one of the biggest in sector
by adminby adminSummary : The Rs 6,480-crore IPO of Gland Pharma, which was launched in November 2020, holds the record for the biggest ever offering in the domestic pharma segment. In August …
-
Covid DrugsPharma Science & Research
Antibodies improve in quality for months after COVID-19 vaccination
by adminby adminSynopsis: For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according to …
-
Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health and Care Excellence (NICE) has passed up the …
-
Pharma Science & Research
Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy
by adminby adminSummary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in Scotland are currently living with epilepsy. Significant treatment …
-
Synopsis : Rare viral haemorrhagic disease similar to Ebola surface in the East of England. Two people in the UK have been diagnosed with Lassa fever, a rare viral haemorrhagic …